Article Details

FTC to block Edwards Lifesciences' acquisition of JenaValve due to competitive concerns

Retrieved on: 2025-08-15 15:01:16

Tags for this article:

Click the tags to see associated articles and topics

FTC to block Edwards Lifesciences' acquisition of JenaValve due to competitive concerns. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... GlobalData estimates the current US TAVR market to be worth $3.2 billion, and forecasts it to grow at a ...

Article found on: www.medicaldevice-network.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo